经颅直流电刺激 (tDCS) 治疗妊娠期抑郁症:一项试点研究
研究概览
详细说明
严重抑郁症是一种严重的疾病,影响多达 10% 的孕妇,并对发育中的胎儿产生严重影响。 然而,目前的治疗方法对患有中度至重度抑郁症的女性来说并不理想。 单独的心理治疗要么无效,要么需要数月才能改善症状,使胎儿在此期间容易患上抑郁症。 抗抑郁药物是有效的,但由于担心药物暴露,标准药物治疗的拒绝率很高。 妊娠期抑郁症对发育中的胎儿和儿童的高度负面影响表明需要及时和创新的治疗方法进行评估。
经颅直流电刺激 (tDCS) 是一种非药物治疗抑郁症的方法,可以直接刺激背外侧前额叶皮层(大脑中在个体抑郁时功能异常的一部分),而不会影响身体或大脑的任何其他部位。 因此,对于不想让胎儿受到抑郁症药物治疗影响的孕妇来说,这是一种理想的治疗方法。 它已被证明对未怀孕的成年人的抑郁症有效,并且通过 3 周的疗程可以迅速改善,几乎是标准心理治疗的 3 倍。 没有已知的严重不良反应,对胎儿没有理论上的风险。
本研究将衡量 tDCS 作为妊娠期抑郁症治疗选择的可行性、可接受性和依从性。 此外,该研究将调查 tDCS 对减轻妊娠期中度至重度抑郁症妇女治疗后立即出现的抑郁症状的影响。
在这项多中心随机对照试验中,将在 1 年的时间内从一个医院的产科小组和两个专业的围产期心理健康诊所招募患有中度至重度妊娠期抑郁症的成年女性。 将向女性提供开始或继续 SSRI(选择性血清素再摄取抑制剂)或 SNRI(选择性血清素-去甲肾上腺素再摄取抑制剂)药物治疗但拒绝使用。 在试验期间,所有参与者将继续从各自的临床项目中接受临床护理。 尽管这种护理可能包括在活跃的 tDCS 治疗阶段完成之前开始的心理治疗干预(如果临床心理治疗候补名单很短),我们预计在心理治疗的前 3 周内不会出现改善。 因此,这是评估新疗法疗效的理想机会,同时又不会剥夺女性接受非药物标准护理的权利。
按照知情同意程序,参与者将被随机分配到 tDCS 或假对照条件 (1:1),并在 30 分钟的疗程中每周 5 天接受现场治疗。 干预是主动 2mA 经颅直流电刺激 (tDCS)。 直流电将通过一对浸有盐水的海绵电极(接触面积 5 x 7cm)传输,并由专门开发的电池驱动的恒流刺激器提供。 根据国际脑电图(脑电图)放置系统,电极将放置在 F3 和 F4 上方。 将使用相同的刺激参数并在主动治疗部位进行假刺激,但电流将在 30 秒后关闭。
妇女将在基线时接受采访,然后在治疗期间接受采访,每四个星期一次直到分娩,并在产后第四周和十二周进行采访,以测量抑郁症状、怀孕、分娩、新生儿和婴儿的结局。 虽然基线和治疗访谈将亲自进行,但治疗后和分娩后访谈将根据参与者的偏好亲自或通过电话进行。
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Ontario
-
Toronto、Ontario、加拿大、M5G 1X5
- Mount Sinai Hospital
-
Toronto、Ontario、加拿大、M5S 1B2
- Women's College Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
纳入标准:
- 年龄 > 18 岁的孕妇
- 入组时妊娠 >12 周
- 第一次治疗就诊时妊娠 32 周或更短(以增加所有治疗在怀孕期间发生的可能性)
- 重度抑郁症的诊断和没有精神病特征的中重度重度抑郁发作(由迷你国际神经精神病学访谈 MINI 证实)。
- 对门诊精神病治疗是安全的(由研究 PI 评估)。
- 提供,但拒绝使用抗抑郁药物
- 能够同意治疗
- 能够理解学习说明并用英语进行问卷调查
排除标准:
- DSM-V 过去 6 个月的酒精和/或物质使用或依赖史
- 伴随的重大和不稳定的内科或神经系统疾病或癫痫病史
- 目前正在服用卡马西平(可能会干扰阳极 tDCS 的作用),
- 研究小组确定的当前妊娠中的主要并发症和/或已知的胎儿异常
- 计划在当前怀孕期间分娩前离开多伦多。
- 颅骨中的金属植入物
- 体内的电子植入物
- 目前每天服用苯二氮卓类药物(允许间歇性使用低剂量劳拉西泮进行 PRN)
- 将放置刺激电极的头皮区域的非完整皮肤
- 前次妊娠有极早产史(< 32 周妊娠)
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:主动 tDCS
干预是主动 2mA 经颅直流电刺激 (tDCS)。
将用一对浸有盐水的海绵电极(接触面积 5 x 7cm)传输直流电,并输送 30 分钟。
根据脑电图放置的 10-20 国际系统,电极将放置在 F3 和 F4 上。
|
干预是主动 2mA 经颅直流电刺激 (tDCS)。
将用一对浸有盐水的海绵电极(接触面积 5 x 7cm)传输直流电,并输送 30 分钟。
根据脑电图放置的 10-20 国际系统,电极将放置在 F3 和 F4 上。
|
|
假比较器:假 tDCS
假干预是经颅直流电刺激 (tDCS)。
用一对浸过盐水的海绵电极(接触面积5×7cm)传递2mA的直流电,54秒后关断电流。电极按10-20国际标准放在F3和F4上脑电图放置系统。
|
假干预是经颅直流电刺激 (tDCS)。
用一对浸过盐水的海绵电极(接触面积5×7cm)传递2mA的直流电,54秒后关断电流。电极按10-20国际标准放在F3和F4上脑电图放置系统。
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
1年以上招募的参与者人数
大体时间:从研究开始招募参与者起最多一年
|
可行性
|
从研究开始招募参与者起最多一年
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
蒙哥马利阿斯伯格抑郁量表
大体时间:第一周结束
|
功效-抑郁症状测量
|
第一周结束
|
|
爱丁堡产后抑郁量表
大体时间:第一周结束
|
功效-抑郁症状测量
|
第一周结束
|
|
妊娠经验量表
大体时间:第一周结束
|
功效 - 次要症状测量
|
第一周结束
|
|
状态特质焦虑量表
大体时间:第一周结束
|
功效 - 次要症状测量
|
第一周结束
|
|
分项新生儿健康结果问卷
大体时间:产后4周
|
新生儿结局(安全性)
|
产后4周
|
|
分项新生儿健康结果问卷
大体时间:产后12周
|
新生儿结局(安全性)
|
产后12周
|
|
贝茨婴儿特征问卷
大体时间:产后12周
|
婴儿结局(气质)
|
产后12周
|
|
年龄和阶段问卷
大体时间:产后12周
|
婴儿结局(发育)
|
产后12周
|
|
多伦多副作用量表
大体时间:第一周结束
|
可接受性——副作用
|
第一周结束
|
|
多伦多副作用量表
大体时间:第 2 周结束
|
可接受性——副作用
|
第 2 周结束
|
|
多伦多副作用量表
大体时间:干预阶段结束(第 3 周结束)
|
可接受性——副作用
|
干预阶段结束(第 3 周结束)
|
|
分项治疗可接受性问卷
大体时间:干预阶段结束(第 3 周结束)
|
可接受性——参加约会的障碍和促进因素
|
干预阶段结束(第 3 周结束)
|
|
妊娠并发症分项问卷
大体时间:第一周结束
|
第一周结束
|
|
|
妊娠并发症分项问卷
大体时间:第 2 周结束
|
第 2 周结束
|
|
|
妊娠并发症分项问卷
大体时间:干预阶段结束(第 3 周结束)
|
干预阶段结束(第 3 周结束)
|
|
|
妊娠并发症分项问卷
大体时间:每 4 周一次,直到婴儿分娩(从初始随机化开始最多 26 周)
|
每 4 周一次,直到婴儿分娩(从初始随机化开始最多 26 周)
|
|
|
妊娠并发症分项问卷
大体时间:产后4周
|
产后4周
|
|
|
后续数据收集率
大体时间:产后12周
|
产后12周
|
|
|
完成所有 15 个疗程
大体时间:干预阶段结束(第 3 周结束)
|
干预阶段结束(第 3 周结束)
|
|
|
治疗分配问卷
大体时间:第一周结束
|
第一周结束
|
|
|
治疗分配问卷
大体时间:干预阶段结束(第 3 周结束)
|
干预阶段结束(第 3 周结束)
|
|
|
蒙哥马利阿斯伯格抑郁量表
大体时间:第 2 周结束
|
功效-抑郁症状测量
|
第 2 周结束
|
|
爱丁堡产后抑郁量表
大体时间:第 2 周结束
|
功效-抑郁症状测量
|
第 2 周结束
|
|
蒙哥马利阿斯伯格抑郁量表
大体时间:干预阶段结束(第 3 周结束)
|
功效-抑郁症状测量
|
干预阶段结束(第 3 周结束)
|
|
蒙哥马利阿斯伯格抑郁量表
大体时间:每 4 周一次,直到分娩(即从初始随机化开始最多 26 周)
|
功效-抑郁症状测量
|
每 4 周一次,直到分娩(即从初始随机化开始最多 26 周)
|
|
蒙哥马利阿斯伯格抑郁量表
大体时间:产后4周
|
功效-抑郁症状测量
|
产后4周
|
|
蒙哥马利阿斯伯格抑郁量表
大体时间:产后12周
|
功效-抑郁症状测量
|
产后12周
|
|
爱丁堡产后抑郁量表
大体时间:干预阶段结束(第 3 周)
|
功效-抑郁症状测量
|
干预阶段结束(第 3 周)
|
|
爱丁堡产后抑郁量表
大体时间:每 4 周一次,直到分娩(即从初始随机化开始最多 26 周)
|
功效-抑郁症状测量
|
每 4 周一次,直到分娩(即从初始随机化开始最多 26 周)
|
|
爱丁堡产后抑郁量表
大体时间:产后4周
|
功效-抑郁症状测量
|
产后4周
|
|
爱丁堡产后抑郁量表
大体时间:产后12周
|
功效-抑郁症状测量
|
产后12周
|
|
妊娠经验量表
大体时间:第 2 周结束
|
功效 - 次要症状测量
|
第 2 周结束
|
|
妊娠经验量表
大体时间:干预阶段结束(第 3 周)
|
功效 - 次要症状测量
|
干预阶段结束(第 3 周)
|
|
妊娠经验量表
大体时间:每 4 周一次,直到分娩(即从初始随机化开始最多 26 周)
|
功效 - 次要症状测量
|
每 4 周一次,直到分娩(即从初始随机化开始最多 26 周)
|
|
状态特质焦虑量表
大体时间:第 2 周结束
|
功效 - 次要症状测量
|
第 2 周结束
|
|
状态特质焦虑量表
大体时间:干预阶段结束(第 3 周结束)
|
功效 - 次要症状测量
|
干预阶段结束(第 3 周结束)
|
|
状态特质焦虑量表
大体时间:每 4 周一次,直到分娩(即从初始随机化开始最多 26 周)
|
功效 - 次要症状测量
|
每 4 周一次,直到分娩(即从初始随机化开始最多 26 周)
|
|
状态特质焦虑量表
大体时间:产后4周
|
功效 - 次要症状测量
|
产后4周
|
|
状态特质焦虑量表
大体时间:产后12周
|
功效 - 次要症状测量
|
产后12周
|
合作者和调查者
调查人员
- 首席研究员:Simone N Vigod, MD, MSc、Women's College Hospital
- 首席研究员:Daniel M Blumberger, MD, MSc、Centre for Addiction and Mental Health
出版物和有用的链接
一般刊物
- Loo CK, Alonzo A, Martin D, Mitchell PB, Galvez V, Sachdev P. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry. 2012 Jan;200(1):52-9. doi: 10.1192/bjp.bp.111.097634.
- Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull. 2007 May 30;72(4-6):208-14. doi: 10.1016/j.brainresbull.2007.01.004. Epub 2007 Jan 24.
- Fregni F, Boggio PS, Nitsche M, Bermpohl F, Antal A, Feredoes E, Marcolin MA, Rigonatti SP, Silva MT, Paulus W, Pascual-Leone A. Anodal transcranial direct current stimulation of prefrontal cortex enhances working memory. Exp Brain Res. 2005 Sep;166(1):23-30. doi: 10.1007/s00221-005-2334-6. Epub 2005 Jul 6.
- Bates JE, Freeland CA, Lounsbury ML. Measurement of infant difficultness. Child Dev. 1979 Sep;50(3):794-803.
- Steer RA, Scholl TO, Hediger ML, Fischer RL. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol. 1992 Oct;45(10):1093-9. doi: 10.1016/0895-4356(92)90149-h.
- Murray L. The impact of postnatal depression on infant development. J Child Psychol Psychiatry. 1992 Mar;33(3):543-61. doi: 10.1111/j.1469-7610.1992.tb00890.x.
- Zuckerman B, Bauchner H, Parker S, Cabral H. Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr. 1990 Aug;11(4):190-4.
- Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988 Aug;45(8):742-7. doi: 10.1001/archpsyc.1988.01800320058007.
- Sandman CA, Wadhwa PD, Dunkel-Schetter C, Chicz-DeMet A, Belman J, Porto M, Murata Y, Garite TJ, Crinella FM. Psychobiological influences of stress and HPA regulation on the human fetus and infant birth outcomes. Ann N Y Acad Sci. 1994 Oct 31;739:198-210. doi: 10.1111/j.1749-6632.1994.tb19822.x. No abstract available.
- Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA. 1993 May 5;269(17):2246-8.
- Orr ST, Miller CA. Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiol Rev. 1995;17(1):165-71. doi: 10.1093/oxfordjournals.epirev.a036172. No abstract available.
- Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996 Oct 3;335(14):1010-5. doi: 10.1056/NEJM199610033351402.
- Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, Ormond K, Matsui D, Stein-Schechman AK, Cook L, Brochu J, Rieder M, Koren G. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA. 1998 Feb 25;279(8):609-10. doi: 10.1001/jama.279.8.609.
- Beck CT. The effects of postpartum depression on child development: a meta-analysis. Arch Psychiatr Nurs. 1998 Feb;12(1):12-20. doi: 10.1016/s0883-9417(98)80004-6.
- Sinclair D, Murray L. Effects of postnatal depression on children's adjustment to school. Teacher's reports. Br J Psychiatry. 1998 Jan;172:58-63. doi: 10.1192/bjp.172.1.58.
- Weinberg MK, Tronick EZ. The impact of maternal psychiatric illness on infant development. J Clin Psychiatry. 1998;59 Suppl 2:53-61.
- Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998 Aug;55(8):694-700. doi: 10.1001/archpsyc.55.8.694.
- Teixeira JM, Fisk NM, Glover V. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. BMJ. 1999 Jan 16;318(7177):153-7. doi: 10.1136/bmj.318.7177.153.
- Ericson A, Kallen B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol. 1999 Sep;55(7):503-8. doi: 10.1007/s002280050664.
- Martins C, Gaffan EA. Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytic investigation. J Child Psychol Psychiatry. 2000 Sep;41(6):737-46.
- Cohen LS, Heller VL, Bailey JW, Grush L, Ablon JS, Bouffard SM. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry. 2000 Nov 15;48(10):996-1000. doi: 10.1016/s0006-3223(00)00877-5.
- Michaud CM, Murray CJ, Bloom BR. Burden of disease--implications for future research. JAMA. 2001 Feb 7;285(5):535-9. doi: 10.1001/jama.285.5.535.
- Speer AM, Kimbrell TA, Wassermann EM, D Repella J, Willis MW, Herscovitch P, Post RM. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000 Dec 15;48(12):1133-41. doi: 10.1016/s0006-3223(00)01065-9.
- Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB, Farrell PM. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res. 1990 May 1;53(2):157-67. doi: 10.1016/0165-3806(90)90002-g.
- Stiskal JA, Kulin N, Koren G, Ho T, Ito S. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed. 2001 Mar;84(2):F134-5. doi: 10.1136/fn.84.2.f134.
- Nordeng H, Lindemann R, Perminov KV, Reikvam A. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr. 2001 Mar;90(3):288-91.
- Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt-Lecuona C. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry. 2001 Jul 1;50(1):58-61. doi: 10.1016/s0006-3223(01)01153-2.
- Hasey G. Transcranial magnetic stimulation in the treatment of mood disorder: a review and comparison with electroconvulsive therapy. Can J Psychiatry. 2001 Oct;46(8):720-7. doi: 10.1177/070674370104600804.
- Oberlander TF, Eckstein Grunau R, Fitzgerald C, Ellwood AL, Misri S, Rurak D, Riggs KW. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res. 2002 Apr;51(4):443-53. doi: 10.1203/00006450-200204000-00008.
- Kelly RH, Russo J, Holt VL, Danielsen BH, Zatzick DF, Walker E, Katon W. Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery. Obstet Gynecol. 2002 Aug;100(2):297-304. doi: 10.1016/s0029-7844(02)02014-8.
- Sharma V. Pharmacotherapy of postpartum depression. Expert Opin Pharmacother. 2002 Oct;3(10):1421-31. doi: 10.1517/14656566.3.10.1421.
- Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002 Nov;159(11):1889-95. doi: 10.1176/appi.ajp.159.11.1889.
- Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med. 2002 Nov;156(11):1129-32. doi: 10.1001/archpedi.156.11.1129.
- Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry. 2002 Dec;159(12):2055-61. doi: 10.1176/appi.ajp.159.12.2055.
- Nitsche MA. Transcranial direct current stimulation: a new treatment for depression? Bipolar Disord. 2002;4 Suppl 1:98-9. doi: 10.1034/j.1399-5618.4.s1.43.x. No abstract available.
- Hammen C, Brennan PA. Severity, chronicity, and timing of maternal depression and risk for adolescent offspring diagnoses in a community sample. Arch Gen Psychiatry. 2003 Mar;60(3):253-8. doi: 10.1001/archpsyc.60.3.253.
- Dennis CL. The effect of peer support on postpartum depression: a pilot randomized controlled trial. Can J Psychiatry. 2003 Mar;48(2):115-24. doi: 10.1177/070674370304800209.
- Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003 Apr;142(4):402-8. doi: 10.1067/mpd.2003.139.
- Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003 Jul;60(7):720-6. doi: 10.1001/archpsyc.60.7.720.
- Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2003 Oct;60(10):1002-8. doi: 10.1001/archpsyc.60.9.1002.
- Nitsche MA, Liebetanz D, Lang N, Antal A, Tergau F, Paulus W. Safety criteria for transcranial direct current stimulation (tDCS) in humans. Clin Neurophysiol. 2003 Nov;114(11):2220-2; author reply 2222-3. doi: 10.1016/s1388-2457(03)00235-9. No abstract available.
- Gjerdingen D. The effectiveness of various postpartum depression treatments and the impact of antidepressant drugs on nursing infants. J Am Board Fam Pract. 2003 Sep-Oct;16(5):372-82. doi: 10.3122/jabfm.16.5.372.
- Lang N, Nitsche MA, Paulus W, Rothwell JC, Lemon RN. Effects of transcranial direct current stimulation over the human motor cortex on corticospinal and transcallosal excitability. Exp Brain Res. 2004 Jun;156(4):439-43. doi: 10.1007/s00221-003-1800-2. Epub 2004 Jan 24.
- Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004 Apr;103(4):698-709. doi: 10.1097/01.AOG.0000116689.75396.5f. Erratum In: Obstet Gynecol. 2004 Jun;103(6):1344.
- Dennis CL. Preventing postpartum depression part I: a review of biological interventions. Can J Psychiatry. 2004 Jul;49(7):467-75. doi: 10.1177/070674370404900708.
- Dennis CL, Stewart DE. Treatment of postpartum depression, part 1: a critical review of biological interventions. J Clin Psychiatry. 2004 Sep;65(9):1242-51. doi: 10.4088/jcp.v65n0914.
- Dennis CL. Treatment of postpartum depression, part 2: a critical review of nonbiological interventions. J Clin Psychiatry. 2004 Sep;65(9):1252-65. doi: 10.4088/jcp.v65n0915.
- Dennis CL. Preventing postpartum depression part II: A critical review of nonbiological interventions. Can J Psychiatry. 2004 Aug;49(8):526-38. doi: 10.1177/070674370404900804. Erratum In: Can J Psychiatry. 2004 Oct;49(10):712.
- Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, de Castella A, Bradshaw JL, Kulkarni J. Motor cortical excitability and clinical response to rTMS in depression. J Affect Disord. 2004 Oct 1;82(1):71-6. doi: 10.1016/j.jad.2003.09.014.
- DiPietro JA, Ghera MM, Costigan K, Hawkins M. Measuring the ups and downs of pregnancy stress. J Psychosom Obstet Gynaecol. 2004 Sep-Dec;25(3-4):189-201. doi: 10.1080/01674820400017830.
- Ardolino G, Bossi B, Barbieri S, Priori A. Non-synaptic mechanisms underlie the after-effects of cathodal transcutaneous direct current stimulation of the human brain. J Physiol. 2005 Oct 15;568(Pt 2):653-63. doi: 10.1113/jphysiol.2005.088310. Epub 2005 Jul 21.
- Fregni F, Boggio PS, Mansur CG, Wagner T, Ferreira MJ, Lima MC, Rigonatti SP, Marcolin MA, Freedman SD, Nitsche MA, Pascual-Leone A. Transcranial direct current stimulation of the unaffected hemisphere in stroke patients. Neuroreport. 2005 Sep 28;16(14):1551-5. doi: 10.1097/01.wnr.0000177010.44602.5e.
- Pilowsky DJ, Wickramaratne PJ, Rush AJ, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Wisniewski SR, Trivedi MH, Talati A, Carlson MM, Liu HH, Fava M, Weissman MM. Children of currently depressed mothers: a STAR*D ancillary study. J Clin Psychiatry. 2006 Jan;67(1):126-36. doi: 10.4088/jcp.v67n0119.
- Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006 Feb 1;295(5):499-507. doi: 10.1001/jama.295.5.499. Erratum In: JAMA. 2006 Jul 12;296(2):170.
- Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006 Feb;160(2):173-6. doi: 10.1001/archpedi.160.2.173.
- Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006 Feb 9;354(6):579-87. doi: 10.1056/NEJMoa052744.
- Fregni F, Boggio PS, Nitsche MA, Marcolin MA, Rigonatti SP, Pascual-Leone A. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord. 2006 Apr;8(2):203-4. doi: 10.1111/j.1399-5618.2006.00291.x. No abstract available.
- Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, Wisniewski SR, Fava M, Hughes CW, Garber J, Malloy E, King CA, Cerda G, Sood AB, Alpert JE, Trivedi MH, Rush AJ; STAR*D-Child Team. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA. 2006 Mar 22;295(12):1389-98. doi: 10.1001/jama.295.12.1389. Erratum In: JAMA. 2006 Sep 13;296(10):1234.
- Fregni F, Boggio PS, Lima MC, Ferreira MJ, Wagner T, Rigonatti SP, Castro AW, Souza DR, Riberto M, Freedman SD, Nitsche MA, Pascual-Leone A. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain. 2006 May;122(1-2):197-209. doi: 10.1016/j.pain.2006.02.023. Epub 2006 Mar 27.
- Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, Walker M. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006 Apr;194(4):961-6. doi: 10.1016/j.ajog.2006.02.019.
- Miranda PC, Lomarev M, Hallett M. Modeling the current distribution during transcranial direct current stimulation. Clin Neurophysiol. 2006 Jul;117(7):1623-9. doi: 10.1016/j.clinph.2006.04.009. Epub 2006 Jun 9.
- Boggio PS, Castro LO, Savagim EA, Braite R, Cruz VC, Rocha RR, Rigonatti SP, Silva MT, Fregni F. Enhancement of non-dominant hand motor function by anodal transcranial direct current stimulation. Neurosci Lett. 2006 Aug 14;404(1-2):232-6. doi: 10.1016/j.neulet.2006.05.051. Epub 2006 Jun 30.
- Fitzgerald PB, Benitez J, de Castella AR, Brown TL, Daskalakis ZJ, Kulkarni J. Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust N Z J Psychiatry. 2006 Sep;40(9):764-8. doi: 10.1080/j.1440-1614.2006.01881.x.
- Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2008 Feb;11(1):131-47. doi: 10.1017/S1461145707007717. Epub 2007 Sep 20.
- Marcus SM, Flynn HA. Depression, antidepressant medication, and functioning outcomes among pregnant women. Int J Gynaecol Obstet. 2008 Mar;100(3):248-51. doi: 10.1016/j.ijgo.2007.09.016. Epub 2007 Nov 19.
- Pilowsky DJ, Wickramaratne P, Talati A, Tang M, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, Weissman MM. Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Am J Psychiatry. 2008 Sep;165(9):1136-47. doi: 10.1176/appi.ajp.2008.07081286. Epub 2008 Jun 16.
- Flynn HA, Chermack ST. Prenatal alcohol use: the role of lifetime problems with alcohol, drugs, depression, and violence. J Stud Alcohol Drugs. 2008 Jul;69(4):500-9. doi: 10.15288/jsad.2008.69.500.
- Dennis CL, Allen K. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006795. doi: 10.1002/14651858.CD006795.pub2.
- Anderson EL, Reti IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med. 2009 Feb;71(2):235-42. doi: 10.1097/PSY.0b013e318190d7ca. Epub 2008 Dec 10.
- Fitzgerald PB, Hoy K, McQueen S, Maller JJ, Herring S, Segrave R, Bailey M, Been G, Kulkarni J, Daskalakis ZJ. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology. 2009 Apr;34(5):1255-62. doi: 10.1038/npp.2008.233. Epub 2009 Jan 14.
- Marcus SM. Depression during pregnancy: rates, risks and consequences--Motherisk Update 2008. Can J Clin Pharmacol. 2009 Winter;16(1):e15-22. Epub 2009 Jan 22.
- Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, Perel JM, Jones-Ivy S, Bodnar LM, Singer LT. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009 May;166(5):557-66. doi: 10.1176/appi.ajp.2008.08081170. Epub 2009 Mar 16.
- Gibson J, McKenzie-McHarg K, Shakespeare J, Price J, Gray R. A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr Scand. 2009 May;119(5):350-64. doi: 10.1111/j.1600-0447.2009.01363.x. Epub 2009 Mar 2.
- Nitsche MA, Boggio PS, Fregni F, Pascual-Leone A. Treatment of depression with transcranial direct current stimulation (tDCS): a review. Exp Neurol. 2009 Sep;219(1):14-9. doi: 10.1016/j.expneurol.2009.03.038. Epub 2009 Apr 5.
- Merzagora AC, Foffani G, Panyavin I, Mordillo-Mateos L, Aguilar J, Onaral B, Oliviero A. Prefrontal hemodynamic changes produced by anodal direct current stimulation. Neuroimage. 2010 Feb 1;49(3):2304-10. doi: 10.1016/j.neuroimage.2009.10.044. Epub 2009 Oct 21.
- Oberlander TF, Gingrich JA, Ansorge MS. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 2009 Dec;86(6):672-7. doi: 10.1038/clpt.2009.201. Epub 2009 Nov 4.
- Dennis CL. Postpartum depression peer support: maternal perceptions from a randomized controlled trial. Int J Nurs Stud. 2010 May;47(5):560-8. doi: 10.1016/j.ijnurstu.2009.10.015. Epub 2009 Dec 4.
- You JJ, Alter DA, Stukel TA, McDonald SD, Laupacis A, Liu Y, Ray JG. Proliferation of prenatal ultrasonography. CMAJ. 2010 Feb 9;182(2):143-51. doi: 10.1503/cmaj.090979. Epub 2010 Jan 4.
- Vigod SN, Villegas L, Dennis CL, Ross LE. Prevalence and risk factors for postpartum depression among women with preterm and low-birth-weight infants: a systematic review. BJOG. 2010 Apr;117(5):540-50. doi: 10.1111/j.1471-0528.2009.02493.x. Epub 2010 Jan 29.
- Ross LE, McQueen K, Vigod S, Dennis CL. Risk for postpartum depression associated with assisted reproductive technologies and multiple births: a systematic review. Hum Reprod Update. 2011 Jan-Feb;17(1):96-106. doi: 10.1093/humupd/dmq025. Epub 2010 Jul 6.
- Ray JG, Schull MJ, Urquia ML, You JJ, Guttmann A, Vermeulen MJ. Major radiodiagnostic imaging in pregnancy and the risk of childhood malignancy: a population-based cohort study in Ontario. PLoS Med. 2010 Sep 7;7(9):e1000337. doi: 10.1371/journal.pmed.1000337.
- Brunoni AR, Valiengo L, Baccaro A, Zanao TA, de Oliveira JF, Vieira GP, Bueno VF, Goulart AC, Boggio PS, Lotufo PA, Bensenor IM, Fregni F. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives. Contemp Clin Trials. 2011 Jan;32(1):90-8. doi: 10.1016/j.cct.2010.09.007. Epub 2010 Sep 18.
- Wickramaratne P, Gameroff MJ, Pilowsky DJ, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, Weissman MM. Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry. 2011 Jun;168(6):593-602. doi: 10.1176/appi.ajp.2010.10010032. Epub 2011 Mar 15.
- Yonkers KA, Vigod S, Ross LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol. 2011 Apr;117(4):961-977. doi: 10.1097/AOG.0b013e31821187a7.
- Rurak D, Lim K, Sanders A, Brain U, Riggs W, Oberlander TF. Third trimester fetal heart rate and Doppler middle cerebral artery blood flow velocity characteristics during prenatal selective serotonin reuptake inhibitor exposure. Pediatr Res. 2011 Jul;70(1):96-101. doi: 10.1203/PDR.0b013e31821ba11a.
- Mulder EJ, Ververs FF, de Heus R, Visser GH. Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology. 2011 Sep;36(10):1961-71. doi: 10.1038/npp.2011.67. Epub 2011 Apr 27.
- Blumberger DM, Mulsant BH, Fitzgerald PB, Rajji TK, Ravindran AV, Young LT, Levinson AJ, Daskalakis ZJ. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression. World J Biol Psychiatry. 2012 Sep;13(6):423-35. doi: 10.3109/15622975.2011.579163. Epub 2011 Jul 8.
- Raimundo RJS, Uribe CE, Brasil-Neto JP. Lack of clinically detectable acute changes on autonomic or thermoregulatory functions in healthy subjects after transcranial direct current stimulation (tDCS). Brain Stimul. 2012 Jul;5(3):196-200. doi: 10.1016/j.brs.2011.03.009. Epub 2011 Apr 27.
- Kalu UG, Sexton CE, Loo CK, Ebmeier KP. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol Med. 2012 Sep;42(9):1791-800. doi: 10.1017/S0033291711003059. Epub 2012 Jan 12.
- Blumberger DM, Christensen BK, Zipursky RB, Moller B, Chen R, Fitzgerald PB, Daskalakis ZJ. MRI-targeted repetitive transcranial magnetic stimulation of Heschl's gyrus for refractory auditory hallucinations. Brain Stimul. 2012 Oct;5(4):577-85. doi: 10.1016/j.brs.2011.12.002. Epub 2012 Feb 22.
- Dennis CL, Ravitz P, Grigoriadis S, Jovellanos M, Hodnett E, Ross L, Zupancic J. The effect of telephone-based interpersonal psychotherapy for the treatment of postpartum depression: study protocol for a randomized controlled trial. Trials. 2012 Apr 19;13:38. doi: 10.1186/1745-6215-13-38.
- Brunoni AR, Vanderhasselt MA, Boggio PS, Fregni F, Dantas EM, Mill JG, Lotufo PA, Bensenor IM. Polarity- and valence-dependent effects of prefrontal transcranial direct current stimulation on heart rate variability and salivary cortisol. Psychoneuroendocrinology. 2013 Jan;38(1):58-66. doi: 10.1016/j.psyneuen.2012.04.020. Epub 2012 May 22.
- Fitzgerald PB, Grace N, Hoy KE, Bailey M, Daskalakis ZJ. An open label trial of clustered maintenance rTMS for patients with refractory depression. Brain Stimul. 2013 May;6(3):292-7. doi: 10.1016/j.brs.2012.05.003. Epub 2012 Jun 1.
- Hanley GE, Oberlander TF. Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a "social teratogen" or moderator of developmental risk? Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):651-9. doi: 10.1002/bdra.23032. Epub 2012 Jun 26.
- Blumberger DM, Tran LC, Fitzgerald PB, Hoy KE, Daskalakis ZJ. A randomized double-blind sham-controlled study of transcranial direct current stimulation for treatment-resistant major depression. Front Psychiatry. 2012 Aug 17;3:74. doi: 10.3389/fpsyt.2012.00074. eCollection 2012.
- Weikum WM, Oberlander TF, Hensch TK, Werker JF. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2(Suppl 2):17221-7. doi: 10.1073/pnas.1121263109. Epub 2012 Oct 8.
- Dennis CL, Heaman M, Vigod S. Epidemiology of postpartum depressive symptoms among Canadian women: regional and national results from a cross-sectional survey. Can J Psychiatry. 2012 Sep;57(9):537-46. doi: 10.1177/070674371205700904.
- Seitz DP, Vigod SN, Lin E, Gruneir A, Newman A, Anderson G, Rapoport MJ, Rochon P, Blumberger DM, Herrmann N. Characteristics of older adults hospitalized in acute psychiatric units in ontario: a population-based study. Can J Psychiatry. 2012 Sep;57(9):554-63. doi: 10.1177/070674371205700906.
- Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721.
- Byatt N, Simas TA, Lundquist RS, Johnson JV, Ziedonis DM. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. J Psychosom Obstet Gynaecol. 2012 Dec;33(4):143-61. doi: 10.3109/0167482X.2012.728649.
- Dennis CL, Coghlan M, Vigod S. Can we identify mothers at-risk for postpartum anxiety in the immediate postpartum period using the State-Trait Anxiety Inventory? J Affect Disord. 2013 Sep 25;150(3):1217-20. doi: 10.1016/j.jad.2013.05.049. Epub 2013 Jun 10.
- Kennedy SH, Lam RW, Cohen NL, Ravindran AV; CANMAT Depression Work Group. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry. 2001 Jun;46 Suppl 1:38S-58S.
- World Health Organization. (WHO). Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products. WHO Technical Report Series, No. 850. (1995). 97-137
- Bricker, D & Squires, J. Ages and Stages Questionnaire. 3rd Ed. Baltimore, MD: Brookes Publishing; 2010.
- GlaxoSmithKline. GSK medicine: Bupropion and Paroxetine. Epidemiology study: Preliminary report on bupropion in pregnancy and the occurrence of cardiovascular and major congenital malformation (Study EPIP083). 2006; http://ctr.gsk.co.uk/summary/paroxetime/epip083.pdf.
- Vigod SN, Kurdyak PA, Dennis CL, Leszcz T, Taylor VH, Blumberger DM, Seitz DP. Transitional interventions to reduce early psychiatric readmissions in adults: systematic review. Br J Psychiatry. 2013 Mar;202(3):187-94. doi: 10.1192/bjp.bp.112.115030.
- Demissie, K, Jospeh, KS, Dzakpasu, S. Perinatal Health Indicators for Canada: A Resource Manual. Public Health Agency of Canda, Canadian Perinatal Surveillance System. 2000; Ottawa, ON.
- Zuckerman B, Amaro H, Bauchner H, Cabral H. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1107-11. doi: 10.1016/0002-9378(89)90170-1.
- O'Hara MW, Swain AM. Rates and risk of postpartum depression: A meta-analysis. International Review of Psychiatry. 1996;8(1):37-54.
- Vigod SN, Murphy KE, Dennis CL, Oberlander TF, Ray JG, Daskalakis ZJ, Blumberger DM. Transcranial direct current stimulation (tDCS) for depression in pregnancy: A pilot randomized controlled trial. Brain Stimul. 2019 Nov-Dec;12(6):1475-1483. doi: 10.1016/j.brs.2019.06.019. Epub 2019 Jun 19.
- Vigod S, Dennis CL, Daskalakis Z, Murphy K, Ray J, Oberlander T, Somerton S, Hussain-Shamsy N, Blumberger D. Transcranial direct current stimulation (tDCS) for treatment of major depression during pregnancy: study protocol for a pilot randomized controlled trial. Trials. 2014 Sep 18;15:366. doi: 10.1186/1745-6215-15-366.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.